A new randomized Phase II clinical trial, OPTIM, is testing whether escalating immune therapy can improve outcomes for people with...
Advanced colorectal cancer remains one of oncology’s toughest challenges, especially in pathological T4 (pT4) disease where outcomes are often grim....
A simple blood test may soon help clinicians manage metastatic castration-resistant prostate cancer (mCRPC) more precisely, according to a study...
Pancreatic cancer remains among the deadliest malignancies, in part because tumors often withstand chemotherapy and later acquire resistance. In recent...
A new analysis reopens one of nutrition science’s most debated questions: whether vegetarian diets change cancer risk. In a commentary...
Brain tumor surgery often hinges on a high-stakes trade-off: maximizing resection while protecting neurological function. Lesions near the corpus callosum...
A new open-access Review in Ferroptosis and Oxidative Stress spotlights Z-nucleic acid-binding protein 1 (ZBP1), framing it as an emerging...
A Huntsman Cancer Institute team at the University of Utah reports that daraxonrasib, a targeted RAS inhibitor, could offer a...
ROCKVILLE, Md.—The Association for Molecular Pathology (AMP) has announced the 2026 recipients of its Award for Excellence in Molecular Diagnostics,...
Researchers at Johns Hopkins Kimmel Cancer Center and the Skip Viragh Center for Pancreatic Cancer report early results from a...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine